These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 18023823

  • 21. Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate.
    Holwell SE, Cooper PA, Thompson MJ, Pettit GR, Lippert LW, Martin SW, Bibby MC.
    Anticancer Res; 2002; 22(6C):3933-40. PubMed ID: 12553015
    [Abstract] [Full Text] [Related]

  • 22. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
    Kong D, Okamura M, Yoshimi H, Yamori T.
    Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509
    [Abstract] [Full Text] [Related]

  • 23. ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature.
    Luo Y, Hradil VP, Frost DJ, Rosenberg SH, Gordon GB, Morgan SJ, Gagne GD, Cox BF, Tahir SK, Fox GB.
    Anticancer Drugs; 2009 Jul; 20(6):483-92. PubMed ID: 19398903
    [Abstract] [Full Text] [Related]

  • 24. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
    Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, Kinashi Y, Ono K.
    Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ, Menke D, Brown JM.
    Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):145-50. PubMed ID: 8270435
    [Abstract] [Full Text] [Related]

  • 26. Effects of tirapazamine on experimental colorectal liver metastases after radiofrequency ablation.
    Govaert KM, Nijkamp MW, Emmink BL, Steller EJ, Minchinton AI, Kranenburg O, Borel Rinkes IH.
    Br J Surg; 2012 Apr 01; 99(4):567-75. PubMed ID: 22331808
    [Abstract] [Full Text] [Related]

  • 27. Nitric oxide synthase inhibition enhances the tumor vascular-damaging effects of combretastatin a-4 3-o-phosphate at clinically relevant doses.
    Tozer GM, Prise VE, Lewis G, Xie S, Wilson I, Hill SA.
    Clin Cancer Res; 2009 Jun 01; 15(11):3781-90. PubMed ID: 19470729
    [Abstract] [Full Text] [Related]

  • 28. Enhancement of bioreductive drug toxicity in murine tumours by inhibition of the activity of nitric oxide synthase.
    Butler SA, Wood PJ, Cole S, Williams C, Adams GE, Stratford IJ.
    Br J Cancer; 1997 Jun 01; 76(4):438-44. PubMed ID: 9275019
    [Abstract] [Full Text] [Related]

  • 29. Determinants of anti-vascular action by combretastatin A-4 phosphate: role of nitric oxide.
    Parkins CS, Holder AL, Hill SA, Chaplin DJ, Tozer GM.
    Br J Cancer; 2000 Sep 01; 83(6):811-6. PubMed ID: 10952787
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of the antiangiogenic potential of AQ4N.
    O'Rourke M, Ward C, Worthington J, McKenna J, Valentine A, Robson T, Hirst DG, McKeown SR.
    Clin Cancer Res; 2008 Mar 01; 14(5):1502-9. PubMed ID: 18316575
    [Abstract] [Full Text] [Related]

  • 31. Histamine-induced modulation of vascular tone in the isolated chicken basilar artery: a possible involvement of endothelium.
    Okuno T, Yabuki A, Shiraishi M, Obi T, Miyamoto A.
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Apr 01; 147(3):339-44. PubMed ID: 18280220
    [Abstract] [Full Text] [Related]

  • 32. Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents.
    Garner AP, Paine MJ, Rodriguez-Crespo I, Chinje EC, Ortiz De Montellano P, Stratford IJ, Tew DG, Wolf CR.
    Cancer Res; 1999 Apr 15; 59(8):1929-34. PubMed ID: 10213502
    [Abstract] [Full Text] [Related]

  • 33. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341
    [Abstract] [Full Text] [Related]

  • 34. Effects of nitric oxide donor and nitric oxide synthase inhibitor on the resistance, exchange and capacitance functions of the canine intestinal vasculature.
    Hsieh NK, Chang HR, Hu CT, Chen HI.
    Vascul Pharmacol; 2008 Nov 20; 48(2-3):122-8. PubMed ID: 18295548
    [Abstract] [Full Text] [Related]

  • 35. Involvement of accumulated NOS inhibitors and endothelin-1, enhanced arginase, and impaired DDAH activities in pulmonary dysfunction following subarachnoid hemorrhage in the rabbit.
    Mizuno Y, Isotani E, Ohno K, Nagai A, Imamura M, Azuma H.
    Vascul Pharmacol; 2008 Jan 20; 48(1):21-31. PubMed ID: 18068544
    [Abstract] [Full Text] [Related]

  • 36. DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine.
    Dorie MJ, Kovacs MS, Gabalski EC, Adam M, Le QT, Bloch DA, Pinto HA, Terris DJ, Brown JM.
    Neoplasia; 1999 Nov 20; 1(5):461-7. PubMed ID: 10933062
    [Abstract] [Full Text] [Related]

  • 37. Vascular targeting agent Oxi4503 inhibits tumor growth in a colorectal liver metastases model.
    Malcontenti-Wilson C, Chan L, Nikfarjam M, Muralidharan V, Christophi C.
    J Gastroenterol Hepatol; 2008 Jul 20; 23(7 Pt 2):e96-e104. PubMed ID: 17559382
    [Abstract] [Full Text] [Related]

  • 38. Impact of cyclic hypoxia on HIF-1alpha regulation in endothelial cells--new insights for anti-tumor treatments.
    Martinive P, Defresne F, Quaghebeur E, Daneau G, Crokart N, Grégoire V, Gallez B, Dessy C, Feron O.
    FEBS J; 2009 Jan 20; 276(2):509-18. PubMed ID: 19077164
    [Abstract] [Full Text] [Related]

  • 39. Phosphorylated histone H2AX in spheroids, tumors, and tissues of mice exposed to etoposide and 3-amino-1,2,4-benzotriazine-1,3-dioxide.
    Olive PL, Banáth JP, Sinnott LT.
    Cancer Res; 2004 Aug 01; 64(15):5363-9. PubMed ID: 15289343
    [Abstract] [Full Text] [Related]

  • 40. Nitric oxide synthase inhibition enhances the antitumor effect of radiation in the treatment of squamous carcinoma xenografts.
    Cardnell RJ, Mikkelsen RB.
    PLoS One; 2011 Aug 01; 6(5):e20147. PubMed ID: 21647438
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.